Vision Improved as Early as 1 Week With Iluvien

At the American Society of Retina Specialists (ASRS) meeting in Vancouver, P. Andrew Pearson, MD, provided an update on the phase 3 clinical trials, collectively known as the FAME study, involving the Iluvien (Alimera Sciences, Inc.) intravitreal insert.1 The FAME study includes 956 patients in the United States, Canad...

Full Story →